Literature DB >> 30587343

Lentivirus mediated γ-interferon-inducible lysosomal thiol reductase (GILT) knockdown suppresses human glioma U373MG cell proliferation.

Sansong Chen1, Qifu Wang1, Xuefei Shao1, Guangfu Di1, Yi Dai1, Xiaochun Jiang2, Limin Cheng3.   

Abstract

BACKGROUND: Glioma is the most common malignancy in brain carcinoma with poor prognosis due to the lack of understanding of the mechanism underlying the disease. γ-interferon-inducible lysosomal thiol reductase (GILT) plays a critical role in the process of antigen processing. However, the role of GILT in the tumorigenesis of glioma remains unknown.
MATERIALS AND METHODS: The expression of GILT was analyzed by bioinformatics using the public database and by qPCR in three human glioma cell lines. Cell growth and viability were determined by Celigo and MTT assays, while cell cycle arrest and apoptosis were determined using flow cytometry. Giemsa staining was used to analyze the colony formation, while cell motility was assessed using transwell migration and invasion assays, as well as, using tumor growth in nude mice.
RESULTS: GILT was highly expressed as observed in the public database on human gliomas and two human glioma cell lines, U373MG and U87MG cells. The downregulation of GILT by lentiviral-mediated silencing inhibits the cell growth, colony formation, and migration but promotes apoptosis and results in cell cycle arrest at the G0/G1 phase in the U373MG cells. Also, the knockdown of GILT inhibits tumor growth in vivo.
CONCLUSION: Elevated GILT is positively associated with glioma progression. GILT silencing suppresses cell proliferation, colony formation, migration, and tumor growth, and induces apoptosis and cell cycle arrest. GILT may serve as a potential target for the treatment of glioma.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cell proliferation; GILT; Glioma; shRNA

Mesh:

Substances:

Year:  2018        PMID: 30587343     DOI: 10.1016/j.bbrc.2018.12.099

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy.

Authors:  Yan Fan; Xu Wang; Yang Li
Journal:  Int J Med Sci       Date:  2021-07-25       Impact factor: 3.738

2.  Expression of gilt acts as a positive regulator of mouse hematopoietic progenitor cells.

Authors:  Hal E Broxmeyer; Scott Cooper; Janice S Blum
Journal:  Blood Cells Mol Dis       Date:  2021-04-30       Impact factor: 2.372

3.  Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.

Authors:  Xiaofeng Yin; Quansheng Wu; Zheng Hao; Laizhao Chen
Journal:  Biomed Eng Online       Date:  2022-04-18       Impact factor: 3.903

4.  IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma.

Authors:  Chen Zhu; Xin Chen; Gefei Guan; Cunyi Zou; Qing Guo; Peng Cheng; Wen Cheng; Anhua Wu
Journal:  Onco Targets Ther       Date:  2020-02-05       Impact factor: 4.147

5.  Effect of cryopreservation on A172 and U251 glioma cells infected with lentiviral vectors designed for CRISPR/Cas9-mediated aquaporin-8 knock-out.

Authors:  Hao Zhang; Shujuan Zhu; Yu Xing; Qian Liu; Zhen Guo; Ziling Cai; Zihao Shen; Qingqian Xia; Huajun Sheng
Journal:  PLoS One       Date:  2022-03-04       Impact factor: 3.240

6.  GILT Expression in Human Melanoma Cells Enhances Generation of Antigenic Peptides for HLA Class II-Mediated Immune Recognition.

Authors:  Jessica D Hathaway-Schrader; Duncan Norton; Katherine Hastings; Bently P Doonan; Shaun Tompkins Fritz; Jennifer R Bethard; Janice S Blum; Azizul Haque
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

7.  NGS Evaluation of Colorectal Cancer Reveals Interferon Gamma Dependent Expression of Immune Checkpoint Genes and Identification of Novel IFNγ Induced Genes.

Authors:  Lai Xu; Lorraine Pelosof; Rong Wang; Hugh I McFarland; Wells W Wu; Je-Nie Phue; Chun-Ting Lee; Rong-Fong Shen; Hartmut Juhl; Lei-Hong Wu; Wei-Lun Alterovitz; Emanuel Petricon; Amy S Rosenberg
Journal:  Front Immunol       Date:  2020-03-19       Impact factor: 7.561

8.  IFI30 expression is an independent unfavourable prognostic factor in glioma.

Authors:  Xiu Liu; Chunyan Song; Shoubo Yang; Qiang Ji; Feng Chen; Wenbin Li
Journal:  J Cell Mol Med       Date:  2020-09-23       Impact factor: 5.310

9.  Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment.

Authors:  Yong Li; Gang Deng; Yangzhi Qi; Huikai Zhang; Lun Gao; Hongxiang Jiang; Zhang Ye; Baohui Liu; Qianxue Chen
Journal:  Med Sci Monit       Date:  2020-08-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.